|
|
|
|
|
|
Free Newsletters
Archive
My eNewsletters
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Login
Become a Member
Discussion Forums
FAQ
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Career Definitions
Labor Market Reports
Education & Training
Regions
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
Intercell AG Q2 Revenue Rises, Net Loss Halves
8/18/2008
VIENNA, Aug 18 (Reuters) - Austrian biotech firm Intercell (ICEL.VI: Quote, Profile, Research, Stock Buzz) reported second-quarter revenue that more than doubled to 9 million euros ($13 million), due to an increase in revenue from collaboration and licensing, it said on Monday. The net loss roughly halved to 4 million euros in the three months to June. The company reiterated it expected positive net income in the full year, despite its acquisition of U.S. biotech group Iomai (IOMI.O: Quote, Profile, Research, Stock Buzz).
|
|
|
|
|
|
|
|
|
|
|
|